| |
| | Special report |
 | | Single enantiomers remain important among the top 300, Ba says, with 158 drugs, which accounted for $64.7 billion out of a total of $124.4 billion. |
 | | The situation is the same for the top 500 drugs, where single enantiomers number 269, with 1997 sales of $71.1 billion, or 52% of $135.9 billion total. |
 | | Sometimes, the pharmaceutical activity is in only one enantiomer and the other is inactive, or the "other" enantiomer has a different kind of activity from the first. |
| pubs.acs.org /hotartcl/cenear/980921/drugs.html (4986 words) |
|